Categories: News

Russell Health: ‘Most Promising Bio Tech Startups 2020’

WILLOWBROOK, Ill., Jan. 4, 2021 /PRNewswire/ — Based in Willowbrook, Illinois, Russell Health, a national marketer and distributor of specialty medical products and services has recently been awarded “Most Promising Bio Tech Startups 2020” by Startup City.

About Russell Health: Russell Health and its partners have distributed regenerative therapy products nationwide and achieved profound clinical outcomes in multiple therapeutic areas including cosmetics, wound care, pain management, podiatry, orthopedics, dentistry and gynecology.

With their partners and suppliers, they work to provide innovative life-changing and sustaining products and therapies to patients and healthcare providers around the world. 

Stem Cell Recruitment Therapy® is Russell Health’s revolutionary procedure to help rejuvenate, regenerate and lubricate ailing joints as well as help to increase mobility while decreasing pain. Responsibly sourced acellular tissue allografts are helping people of all ages to recover from injuries and get their life back.

In honor of their achievements, StartUp City has featured an article about the innovators titled: “Russell Health: Bringing Life-Changing Innovation through Regenerative Medicine.” Read the full article here.

Article Quote:

“Jonathan Benstent notes: Regenerative medicine is transforming healthcare innovations that have shown to provide improved patient care and increased quality of life. The cutting-edge and less invasive technologies help the body repair itself through its unique healing capabilities and are a powerful alternative to risk-prone surgeries. When Ryan Salvino, an MBA graduate and an enthusiast in medicine, experienced this revitalizing effect first-hand while working as a sales representative for a regenerative medicine company, and it was nothing less than a miracle. “I saw the before and after effect in patients intimately and it’s incredible how effective, painless, and safe these products are for the treatment of multiple disorders throughout the body,” recalls Salvino. (startupcity.com, 2020)

Client Testimonials: 

“The customer service from the company has been exceptional. Russell Health is easily reachable by phone and always happy to provide guidance as needed.” (Dr. Yula Indeyeva, MD)

“Thank you so much for training each of our departments from our medical staff to front desk to the billing department. I thought I was going to have to do everything BUT you did it for us. The staff loved the training and each department knows exactly what they must do to implement this product.” (Dr. Chris Pellow)

Visit Russell Health online to learn more about Stem Cell Recruitment Therapy®. For media inquiries or to contact the Russell Health team directly. Please visit www.russellhealth.com or email marketing@russellhealth.com.

Contact: Veronica Bennett

Phone: 312-919-1896

Email: marketing@russellhealth.com

Mailing Address: 621 Plainfield Rd., Willowbrook, IL 60527

Online: www.russellhealth.com

Related Files

cropped-RussellHealth-Tagline-FullColor-RGB-300×179.png

pp540_3003008541984.jpg

Related Images

russell-health-most-promising.png
Russell Health – Most Promising BioTech Startups 2020
Startup City – Most Promising BioTech Startup of 2020 – Russell Health – Ryan Salvino

Related Links

Stem Cell Recruitment Therapy® – Info

Stem Cell Recruitment Therapy® – Explainer Video

View original content to download multimedia:http://www.prnewswire.com/news-releases/russell-health-most-promising-bio-tech-startups-2020-301200383.html

SOURCE Russell Health

Staff

Recent Posts

Global Microscopy Market to Reach USD 10.6 Billion by 2029 driven by Healthcare Innovations | MarketsandMarkets™

CHICAGO, July 4, 2024 /PRNewswire/ -- The global microscopy market is poised for significant growth, expected…

9 hours ago

FSD Pharma Files Amended and Restated Material Change Report

Toronto, Ontario--(Newsfile Corp. - July 4, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE)…

12 hours ago

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) -- Global biotechnology leader CSL Behring (ASX: CSL)…

12 hours ago

ICPO Foundation partners with Nuclear Medicine Research Infrastructure (NuMeRI) to establish an ICPO Collaborating Center

ICPO Center NuMeRI ICPO Foundation signed the contract with Nuclear Medicine Research Infrastructure (NuMeRI) to…

12 hours ago